third quarter earnings conference call february 6 2020
play

Third Quarter Earnings Conference Call February 6, 2020 Quarter - PowerPoint PPT Presentation

Third Quarter Earnings Conference Call February 6, 2020 Quarter Ended December 31, 2019 Cautionary Statement Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's


  1. Third Quarter Earnings Conference Call February 6, 2020 Quarter Ended December 31, 2019

  2. Cautionary Statement Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates" or other similar expressions and future or conditional verbs such as “will,” “should,” “would,” and “could” are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise. Factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following: (i) the failure to complete our merger with Yageo Corporation (the “Merger”), (ii) certain business uncertainties and contractual restrictions related to the pendency of the Merger, (iii) our inability to pursue alternatives to the Merger during the pendency of the Merger, (iv) lawsuits filed against us relating to the Merger, (v) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate and could cause a write down of long-lived assets or goodwill; (vi) an increase in the cost or a decrease in the availability of our principal or single- sourced purchased raw materials; (vii) changes in the competitive environment; (viii) uncertainty of the timing of customer product qualifications in heavily regulated industries; (ix) economic, political, or regulatory changes in the countries in which we operate; (x) difficulties, delays, or unexpected costs in completing the Company’s restructuring plans; (xi) acquisitions and other strategic transactions expose us to a variety of risks, including the ability to successfully integrate and maintain adequate internal controls over financial reporting in compliance with applicable regulations; (xii) our acquisition of TOKIN Corporation may not achieve all of the anticipated results; (xiii) our business could be negatively impacted by increased regulatory scrutiny and litigation; (xiv) difficulties associated with retaining, attracting, and training effective employees and management; (xv) the need to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xvi) exposure to claims alleging product defects; (xvii) the impact of laws and regulations that apply to our business, including those relating to environmental matters, data protection, cyber security and privacy; (xviii) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xix) changes impacting international trade and corporate tax provisions related to the global manufacturing and sales of our products may have an adverse effect on our financial condition and results of operations; (xx) volatility of financial and credit markets affecting our access to capital; (xxi) default or failure of one or more of our counterparty financial institutions could cause us to incur significant losses; (xxii) the need to reduce the total costs of our products to remain competitive; (xxiii) potential limitation on the use of net operating losses to offset possible future taxable income; (xxiv) restrictions in our debt agreements that could limit our flexibility in operating our business; (xxv) failure to maintain effective internal controls over financial reporting; (xxvi) service interruption, misappropriation of data, or breaches of security as it relates to our information systems could cause a disruption in our operations, financial losses, and damage to our reputation; (xxvii) economic and demographic experience for pension and other post-retirement benefit plans could be less favorable than our assumptions; (xxviii) fluctuation in distributor sales could adversely affect our results of operations; (xxix) earthquakes and other natural disasters could disrupt our operations and have a material adverse effect on our financial 2 condition and results of operations; and (xxx) volatility in our stock price.

  3. Income Statement Highlights GAAP (Unaudited) For the Quarters Ended Dec 2019 Dec 2018 (Amounts in thousands, except percentages and per share data) Net sales $ 294,741 $ 350,175 Gross margin $ 93,181 $ 123,750 Gross margin as a percentage of net sales 31.6% 35.3% Selling, general and administrative $ 50,031 $ 48,271 SG&A as a percentage of net sales 17.0% 13.8% Operating income $ 28,648 $ 61,616 Income tax expense $ 5,400 $ 2,600 Net income $ 16,602 $ 40,806 Per basic and diluted share data: Net income per basic share $ 0.28 $ 0.70 Net income per diluted share $ 0.28 $ 0.69 Weighted avg. shares - basic 58,646 58,010 Weighted avg. shares - diluted 59,529 59,111 3

  4. Income Statement Highlights Non-GAAP (Unaudited) (1) For the Quarters Ended Dec 2019 Dec 2018 (Amounts in thousands, except percentages and per share data) Net sales (GAAP) $ 294,741 $ 350,175 Adjusted gross margin $ 94,109 $ 124,721 Adjusted gross margin as a percentage of net sales 31.9% 35.6% Adjusted selling, general and administrative $ 41,194 $ 43,783 Adjusted SG&A as a percentage of net sales 14.0% 12.5% Adjusted operating income $ 40,365 $ 69,682 Income tax expense $ 11,093 $ 2,691 Adjusted net income $ 27,594 $ 62,658 Adjusted EBITDA $ 56,740 $ 82,020 Adjusted EBITDA margin as a percentage of net sales 19.3% 23.4% Per share data: Adjusted net income per basic share $ 0.47 $ 1.08 Adjusted net income per diluted share $ 0.46 $ 1.06 Weighted avg. shares - basic 58,646 58,010 Weighted avg. shares - diluted 59,529 59,111 (1) For a reconciliation of the non-GAAP measures presented on this slide to their most directly comparable GAAP measure, see the 4 appendix.

  5. LTM Adjusted EBITDA Margins Non-GAAP (Unaudited) (1) 24% 23% 23.1% 22.6% 22.2% 22% 21% 20.9% 20% 19.3% 19% 18% Dec Mar Jun Sep Dec 2018 2019 2019 2019 2019 (1) For a reconciliation of the non-GAAP measures presented on this slide to their most directly comparable GAAP measure, see the 5 appendix.

  6. Adjusted Selling, General & Administrative Expenses Reconciliation Non-GAAP (Unaudited) For the Quarters Ended Dec 2019 Dec 2018 (Amounts in thousands, except percentages) Net sales (GAAP) $ 294,741 $ 350,175 Selling, general and administrative expenses (GAAP) $ 50,031 $ 48,271 Selling, general, and administrative as a percentage of net sales 17.0% 13.8% Less non-GAAP adjustments: ERP integration/IT transition costs 2,029 2,453 Stock-based compensation expense 1,521 767 Legal expenses related to antitrust class actions (29) 1,268 Contingent consideration fair value adjustment 33 — Merger related expenses 5,283 — Adjusted selling, general and administrative expenses (non-GAAP) $ 41,194 $ 43,783 Adjusted selling, general, and administrative as a percentage of net sales 14.0% 12.5% 6

  7. Financial Highlights (Unaudited) Dec 2019 Sep 2019 (Amounts in millions) Cash, cash equivalents $ 208.4 $ 192.7 Inventories, net $ 263.1 $ 268.2 Capital expenditures $ 30.8 $ 36.2 Short-term debt $ 29.0 $ 29.2 Long-term debt 301.5 292.7 Debt (discount)/premium and issuance costs (18.8) (16.3) Total debt $ 311.7 $ 305.6 Equity $ 687.3 $ 650.9 Net working capital (1) $ 293.7 $ 248.8 (1) Calculated as accounts receivable, net, plus inventories, net, less accounts payable. 7

  8. Net Debt (Unaudited) Net Debt (Debt less Cash on hand) $ (Millions) $278 $113 $103 $95 $87 $38 FY17 FY18 FY 19 Q1 20 Q2 20 Q3 20 8

  9. Leverage Non-GAAP (Unaudited) (1) Leverage (Net Debt/Adjusted EBITDA) 2.6 0.4 0.4 0.3 0.3 0.2 FY17 FY 18 FY19 6/30/19 LTM 9/30/19 LTM 12/31/19 LTM (1) For a reconciliation of the non-GAAP measures presented on this slide to their most directly comparable GAAP measure, see the 9 appendix.

  10. Financial Trends Quarterly Sales Summary GAAP (Unaudited) Net Sales 360 $356 350 $350 $345 340 330 $327 320 $ (Millions) 310 300 $295 290 280 270 260 250 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 10

  11. Sales Summary - Q3 FY2020 (Unaudited) INDUSTRY CHANNEL Def/Med Telecom 10% 13% Automotive Distributors 14% OEM 39% Computer 44% 22% Ind/Light 26% Consumer EMS 15% 17% REGION PRODUCT LINE MSA Americas 16% 22% Tantalum APAC 39% F&E 43% 15% EMEA 21% Ceramics JPKO 30% 14% 11

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend